Drug delivery device

- Avaxzipen Limited

Latest Avaxzipen Limited Patents:

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front left perspective view of a drug delivery device;

FIG. 2 is a front right perspective view thereof;

FIG. 3 is a front perspective view thereof;

FIG. 4 is a front left perspective view thereof;

FIG. 5 is a front right perspective view thereof;

FIG. 6 is a front perspective view thereof;

FIG. 7 is a front left perspective view thereof;

FIG. 8 is a front right perspective view thereof;

FIG. 9 is a front perspective view thereof;

FIG. 10 is a front left perspective view thereof;

FIG. 11 is a front right perspective view thereof; and,

FIG. 12 is a front perspective view thereof.

The broken lines in the drawings illustrate portions of the drug delivery device and form no part of the claimed design.

Claims

The ornamental design for a drug delivery device, as shown and described.

Referenced Cited
U.S. Patent Documents
D428650 July 25, 2000 Bellhouse et al.
D479748 September 16, 2003 Tyce
D481120 October 21, 2003 Hawley
D548336 August 7, 2007 Galbraith
D555609 November 20, 2007 Galbraith
D567939 April 29, 2008 Mattigka
D619244 July 6, 2010 Van der Stappen
D676547 February 19, 2013 Quinn et al.
D705924 May 27, 2014 Hunter
D705925 May 27, 2014 Murray
D749719 February 16, 2016 Sanders et al.
D770611 November 1, 2016 Saussaye et al.
D776261 January 10, 2017 Jones et al.
D786423 May 9, 2017 Jones et al.
D790687 June 27, 2017 Jones et al.
D792578 July 18, 2017 Jones et al.
D800898 October 24, 2017 Sanders et al.
D808010 January 16, 2018 Denzer
D862690 October 8, 2019 Jansen
D878563 March 17, 2020 Clawson et al.
D886281 June 2, 2020 Boyaval et al.
D888942 June 30, 2020 Cannamela et al.
D890918 July 21, 2020 Fritz et al.
D915584 April 6, 2021 Eisenkrein et al.
D926967 August 3, 2021 Rogge et al.
D926973 August 3, 2021 Andersen et al.
D982744 April 4, 2023 Ryan
D994120 August 1, 2023 Li
20180028798 February 1, 2018 Conlon et al.
Foreign Patent Documents
6056759 March 2019 GB
357381-001 May 2023 IN
Other references
  • AVaxziPen needle-free vaccine, aVaxziPen, European Pharmaceutical Manufacturer, [Post date: Apr. 3, 2023], [Site seen: May 6, 2024], Seen aT URL: https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/drug-delivery-news/avaxzipen-announces-positive-data-on-novel-needle-free-%E2%80%A61/4 (Year: 2023).
  • Whisperject autoinjector, Glatiramer Acetate Injection, [Post date: unknown], [Site seen: May 6, 2024], Seen at URL: https://www.glatirameracetatehcp.com/en/injection-support (Year: 2024).
  • Kutepatil, O., “Enisi Pharma form an R&D collaboration with Public Health England”, Oct. 2, 2018, news release, retrieved Aug. 24, 2022 from http://exsoft.org/enesi-pharma-forms-rd-public-health-england/ (Year: 2018).
Patent History
Patent number: D1055274
Type: Grant
Filed: Apr 26, 2022
Date of Patent: Dec 24, 2024
Assignee: Avaxzipen Limited (Abingdon)
Inventors: Owen Ryan (Bray), David Andrew Grant (Faringdon), Ritwik (Harwell)
Primary Examiner: Natasha Vujcic
Assistant Examiner: Gilbert B Ford
Application Number: 29/836,339